A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

317

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

November 30, 2009

Study Completion Date

July 31, 2011

Conditions
Macular Edema Associated With Diabetes Mellitus
Interventions
DRUG

Standard of Care

Clinicians decision to use optional laser therapy.

DRUG

Macugen

Intravitreal injection of Macugen 0.3mg/90ul every 6 weeks up to 2 years.

Trial Locations (73)

2145

Pfizer Investigational Site, Westmead

2600

Pfizer Investigational Site, Glostrup Municipality

6500

Pfizer Investigational Site, Nijmegen

9301

Pfizer Investigational Site, Bloemfontein

10021

Pfizer Investigational Site, New York

11563

Pfizer Investigational Site, Lynbrook

12462

Pfizer Investigational Site, Athens

13008

Pfizer Investigational Site, Marseille

Pfizer Investigational Site, Marsielle

13385

Pfizer Investigational Site, Marseille

15213

Pfizer Investigational Site, Pittsburgh

20132

Pfizer Investigational Site, Milan

28210

Pfizer Investigational Site, Charlotte

29169

Pfizer Investigational Site, West Columbia

30909

Pfizer Investigational Site, Augusta

33100

Pfizer Investigational Site, Udine

33609

Pfizer Investigational Site, Tampa

33612

Pfizer Investigational Site, Tampa

40225

Pfizer Investigational Site, Düsseldorf

46280

Pfizer Investigational Site, Indianapolis

48145

Pfizer Investigational Site, Münster

50005

Pfizer Investigational Site, Hradec Králové

50134

Pfizer Investigational Site, Florence

53105

Pfizer Investigational Site, Bonn

53226

Pfizer Investigational Site, Milwaukee

54035

Pfizer Investigational Site, Nancy

63003

Pfizer Investigational Site, Clermont

67214

Pfizer Investigational Site, Wichita

69006

Pfizer Investigational Site, Lyon

69120

Pfizer Investigational Site, Heidelberg

72706

Pfizer Investigational Site, Tübingen

75571

Pfizer Investigational Site, Paris

76104

Pfizer Investigational Site, Fort Worth

76508

Pfizer Investigational Site, Temple

77002

Pfizer Investigational Site, Houston

78240

Pfizer Investigational Site, San Antonio

78503

Pfizer Investigational Site, McAllen

79606

Pfizer Investigational Site, Abilene

80230

Pfizer Investigational Site, Denver

85020

Pfizer Investigational Site, Phoenix

85704

Pfizer Investigational Site, Tucson

90095

Pfizer Investigational Site, Los Angeles

92705

Pfizer Investigational Site, Santa Ana

94010

Pfizer Investigational Site, Créteil

94609

Pfizer Investigational Site, Oakland

96701

Pfizer Investigational Site, ‘Aiea

06518

Pfizer Investigational Site, Hamden

33334-4146

Pfizer Investigational Site, Fort Lauderdale

02114

Pfizer Investigational Site, Boston

48201-1423

Pfizer Investigational Site, Detroit

Unknown

Pfizer Investigational Site, East Melbourne

Pfizer Investigational Site, Bogotá

A-6020

Pfizer Investigational Site, Innsbruck

A-1180

Pfizer Investigational Site, Vienna

74210-010

Pfizer Investigational Site, Gioania

90035-003

Pfizer Investigational Site, Porto Alegre

04524-020

Pfizer Investigational Site, São Paulo

SP 04524-20

Pfizer Investigational Site, São Paulo

V5Z 3N9

Pfizer Investigational Site, Vancouver

H1T 2H1

Pfizer Investigational Site, Montreal

625 00

Pfizer Investigational Site, Brno

775 20

Pfizer Investigational Site, Olomouc

140 00

Pfizer Investigational Site, Prague

169 00

Pfizer Investigational Site, Prague

04103

Pfizer Investigational Site, Leipzig

380 004

Pfizer Investigational Site, Ahmedabad

560 085

Pfizer Investigational Site, Bangalore

500 034

Pfizer Investigational Site, Hyderabad

110 029

Pfizer Investigational Site, New Delhi

3000-354

Pfizer Investigational Site, Coimbra

CH-3010

Pfizer Investigational Site, Bern

NE1 4LP

Pfizer Investigational Site, Newcastle upon Tyne

S10 2JF

Pfizer Investigational Site, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00605280 - A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension. | Biotech Hunter | Biotech Hunter